New contact lens trial aims to stop worsening eyesight in children

NCT ID NCT05159765

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether NaturalVue multifocal contact lenses can slow the progression of myopia (nearsightedness) in children aged 7 to 12. Over three years, 144 kids will wear either standard single-vision lenses or the multifocal lenses. Researchers will measure changes in their prescription and eye length to see if the multifocal design helps control myopia.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
contact lenses
What this could lead to
If successful, this could provide a simple, non-invasive way to slow worsening nearsightedness in children, reducing their risk of serious eye problems later in life.
What could go wrong
This is a mid-stage trial with 144 participants, so results may not apply to everyone. The lenses are already approved for vision correction, but their ability to slow myopia progression is still being tested.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bellaire Family Eye Care

    Bellaire, Texas, 77401, United States

  • Cooper Eye Care

    New York, New York, 10065, United States

  • Fig Garden Optometry

    Fresno, California, 93704, United States

  • Hong Kong Polytechnic University

    Tsim Sha Tsui, Hong Kong

  • Myopia Specialist Centre

    Singapore, Singapore

  • North Suburban Vision Consultants

    Deerfield, Illinois, 60015, United States

  • Toronto Eye Care

    Toronto, Ontario, M4W 1A5, Canada

  • University of Waterloo School of Optometry

    Waterloo, Ontario, N2L 3G1, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.